A study reported by Nadeem A et al. had shown that GPR43 agonists could activate epidermal GPR43-mediated DUOX2 and IL-6 signaling pathways to give rise to pernicious ROS, leading to Th17 polarization immune responses and deterioration of psoriasis [42]. Here, FFAR2 is linked to psoriasis.